
Almac Group, a global contract pharmaceutical development and manufacturing organisation, has announced that it will spend £27 million in a …

The Almac Group’s Clinical Technologies business unit has announced that Charlie Morris has joined the company as vice president of …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

